Skip to main content
Home

National Network for Equitable Library Service

The Canadian Accessible Library System (D10 Beta)

Menu
  • English
  • Français

User menu

  • Log in
Sign Up Login

Search the NNELS collection:

Main menu

  • Home
  • Tutorials
  • Info for Libraries
  • Grant Projects
  • News
  • About

Breadcrumb

  1. Home
  2. Acceptable Risk

Acceptable risk

Available Formats:

Details:

  • Author: Cook, Robin
    Summary:

    The bestselling “master of the medical thriller” (The New York Times) confronts one of the most compelling issues of our time: personality-altering drugs and the complex moral questions they raise. When neuroscientist Edward Armstrong begins dating Kimberly Stewart, a descendant of a woman who was hanged as a witch at the time of the Salem witch trials, he takes advantage of the opportunity to delve into a pet theory: that the “devil” in Salem in 1692 had been a hallucinogenic drug inadvertently consumed with mold-tainted grain. In an attempt to prove his theory, Edward grows the mold he believes responsible with samples from the Stewart estate. In a brilliant designer-drug transformation, the poison becomes Ultra, the next generation of antidepressants with truly startling therapeutic capabilities. But who can be sure the drug is safe for consumers? Who defines the boundaries of “normal” human behavior? And if the drug’s side effects are proven to be dangerous—even terrifying—how far will the medical community go to alter their standards of acceptable risk?

    Genre: Medical fiction, Thrillers (Fiction)
    Original Publisher: New York , G.P. Putnam's Sons , New York , Putnam
    Language(s): English
    ISBN:

    9781101203552

Details

Abstract

The bestselling “master of the medical thriller” (The New York Times) confronts one of the most compelling issues of our time: personality-altering drugs and the complex moral questions they raise. When neuroscientist Edward Armstrong begins dating Kimberly Stewart, a descendant of a woman who was hanged as a witch at the time of the Salem witch trials, he takes advantage of the opportunity to delve into a pet theory: that the “devil” in Salem in 1692 had been a hallucinogenic drug inadvertently consumed with mold-tainted grain. In an attempt to prove his theory, Edward grows the mold he believes responsible with samples from the Stewart estate. In a brilliant designer-drug transformation, the poison becomes Ultra, the next generation of antidepressants with truly startling therapeutic capabilities. But who can be sure the drug is safe for consumers? Who defines the boundaries of “normal” human behavior? And if the drug’s side effects are proven to be dangerous—even terrifying—how far will the medical community go to alter their standards of acceptable risk?

Genre
Medical fiction
Thrillers (Fiction)
Publisher (Source)

New York

G.P. Putnam's Sons

New York

Putnam

Not specified

Record

Main menu

  • Home
  • Tutorials
  • Info for Libraries
  • Grant Projects
  • News
  • About

Questions about NNELS? Contact us!

Email: support@nnels.ca

Phone: 1-888-848-9250

Hours: 9 to 4 Pacific Time, Monday to Friday

Follow us: Bluesky, Facebook, YouTube, Linkedin

Subscribe to our newsletter.

Four blue figures are waving, two adults and two children, with the text living wage employer

Accessible Books Consortium logo, an open book with A, B, and C in text and braille Daisy logo, two blue swoops above and below the word DAISY The European Digital Reading Lab logo, a blue circle with EDRLab in the middle